Aristo Pharma Nordic ApS: Financial statements 2017
CVR: 32328768
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Aristo Pharma Nordic ApS (CVR 32328768) has filed annual accounts for 2017. In 2017, the company reported a gross profit of EUR -3,906,558 and a net result of EUR -5,014,436 compared with EUR -2,070,042 the year before. Equity in the 2017 report amounted to EUR -1,173,992. The company had 10 employees in the financial year.
- Gross Profit
- EUR -3,906,558
- Profit/Loss
- EUR -5,014,436
- Equity
- EUR -1,173,992
- Total Assets
- EUR 6,778,323
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -3.9 mio. EUR | -5 mio. EUR | -1.2 mio. EUR | 10 |
| 2016 | - | -475 t. EUR | -2.1 mio. EUR | -4.7 mio. EUR | 12 |
| 2015 | - | 145 t. EUR | -1.6 mio. EUR | -2.7 mio. EUR | 11 |
| 2014 | - | -734 t. EUR | -1.7 mio. EUR | -1.1 mio. EUR | 12 |
| 2012 | - | -297 t. | -428 t. | -484 t. | - |
Official annual report
Keep an eye on Aristo Pharma Nordic ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
On October 26, 2017, the company changed its name from AMNEAL NORDIC ApS to Aristo Pharma Nordic ApS.
As of October 4, 2017, Hasnain Nasir Butt has joined the board of directors of Aristo Pharma Nordic ApS.
As of October 4, 2017, Sascha Rauschke has joined the board of directors of Aristo Pharma Nordic ApS.
As of October 4, 2017, Anton Alwin Karremann has joined the board of directors of Aristo Pharma Nordic ApS.
As of October 4, 2017, Chirag K Patel has left the board of directors of Aristo Pharma Nordic ApS.
As of October 4, 2017, Chintu Patel has left the board of directors of Aristo Pharma Nordic ApS.
As of October 4, 2017, János Váczi has left the board of directors of Aristo Pharma Nordic ApS.
As of October 4, 2017, Hasnain Nasir Butt is registered as director of Aristo Pharma Nordic ApS.
As of October 4, 2017, János Váczi has stepped down as director of Aristo Pharma Nordic ApS.
As of October 4, 2017, is registered as an owner of Aristo Pharma Nordic ApS with an ownership share of 100%.
About Aristo Pharma Nordic ApS
Aristo Pharma Nordic ApS is a Danish company of the type Anpartsselskab based in Skovlunde, founded in 2011. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named AMNEAL NORDIC ApS and COPHARMA ApS. The management consists of John Hudson Kriwet. The board consists of John Hudson Kriwet (chair), Jannes Paul Beeskow and Robert Maciej Szymanski. The company is owned by Aristo Pharma GmbH. The company has 1 employee (2026). In 2025, the company reported revenue of EUR 453,392 and a net result of EUR 21,589 compared with EUR 25,190 the year before. Equity in the 2025 report amounted to EUR 184,874.